DIKUL - logo
ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy-acetyl)-L-alanyl-D-glutamic acid (LK-423) : patent : EP 1734933 (B1), 2010-05-26
    Bogataj, Marija, 1963- ...
    The present invention relates to the pharmaceutical dosage forms which enabled a controlled and/or a targeted drug delivery of an active substance tothe selected regions of gastrointestinal tract of ... humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2phthalimidoethoxy-acetyl)-L-alanyl-D-glutamic acid (designed as LK-423).Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed.
    Type of material - patent ; adult, serious
    Publication and manufacture - Munich : European Patent Office, 2010
    Language - english
    COBISS.SI-ID - 1812337

No library within the COBISS.SI system holds a copy of this material.
loading ...
loading ...
loading ...